CURRICULUM VITAE
Darius R. Mehregan, MD
Office Address: 18100 Oakwood Boulevard 2nd Office Address: 1314 N. Macomb Street Dearborn, Michigan 48124 Monroe, Michigan 48162
EDUCATION University of Michigan, Medical School 1984 – 1988
University of Michigan, Ann Arbor, Michigan 1980 – 1984 Bachelor of Science, Biology, Graduated with High Honors
RESEARCH – Fellowships
University of Michigan, Department of Dermatology 1988 Electron microscopic study of U.V. induced antigen presenting cells.
University of Michigan, Department of Neurology 1985 Electron microscopic study of receptor changes in the development of the rat globus pallidus.
MEDICAL TRAINING Fellowship Dermatopathology 1992 – 1993 New York University, New York, NY
Residency Department of Dermatology 1989 – 1992 Mayo Clinic, Rochester, Minnesota
Internship Department of Internal Medicine 1988 – 1989 University of Michigan Hospitals
FACULTY APPOINTMENTS Clinical Associate Professor, Michigan State University, Department of OMS 2012-Present Clinical Assistant Professor, Pathology, University of Toledo; Toledo, OH 2004-Present Professor – Wayne State University; Detroit, MI 2006-Present Hermann Pinkus Chairman of Dermatology, Wayne State University; Detroit, MI 2006-Present
QF.6.2.1.01 1 08/02/2016 HOSPITAL OR OTHER PROFESSIONAL APPOINTMENTS President – Michigan Dermatological Society 2016-Present Staff Dermatologist – Detroit Medical Center; Detroit, MI 2006-Present Staff Dermatologist – Oakwood Medical Center; Dearborn, MI 2006-Present Staff Dermatologist – Children’s Hospital of Michigan; Detroit, MI 2006-Present Staff Dermatologist – Karmanos Cancer Institute; Detroit, MI 2006-Present Staff Dermatologist – J. Dingell VA Medical Center; Detroit, MI 1995-Present Dermatopathologist – Pinkus Laboratory; Monroe, MI 1993-Present
PROFESSIONAL SOCIETIES International Society of Dermatology 2001-Present Western Lake Erie Dermatologic Society 2000-Present Society of Investigative Dermatology 1995-Present International Society of Dermatopathology 1994-Present Monroe County Medical Society 1994-Present American Medical Association 1994-Present Fellow American Academy of Dermatology 1993-Present American Society of Dermatopathology 1993-Present
MEDICAL LICENSURE Ari zo na 45522 Expiration 12/10/2015 Florida ME 72293 Expiration 01/31/2016 Idaho M11504 Expiration 06/30/2015 Illinois 36 128155 Expiration 07/31/2017 Indiana 01069843A Expiration 10/31/2015 Iowa 40104 Expiration 12/01/2015 Michigan 4301053251 Expiration 01/31/2018 New York 263775 Expiration 11/30/2014 North Dakota PT 12178 Expiration 12/10/2014 Ohio 35 065069 Expiration 07/01/2016 Pennsylvania MD445656 Expiration 12/31/2014 Tennessee MD0000048089 Expiration 12/31/2015 Virginia 101251344 Expiration 12/31/2014 Washington MD60251629 Expiration 12/10/2014 West Virginia 24813 Expiration 06/30/2015 Wisconsin 56812-20 Expiration 10/31/2015
BOARD CERTIFICATION American Board of Dermatology & Pathology 1993 American Board of Dermatology (Recertified 2010) 1992
HONORS Outstanding Faculty Member - Wayne State University 1996, 1999, 2005, 2011 Paul A. O'Leary Award in Dermatology - Mayo Clinic 1992 American Society of Dermatopathology - Best Oral Presentation by a Resident 1991 William B. Taylor Dermatology Award - University of Michigan 1988 Alpha Omega Alpha Medical Honor Society - University of Michigan 1987 James B. Angell Scholar - University of Michigan 1984 Phi Beta Kappa National Honor Society - University of Michigan 1984 Undergraduate Class Honors - University of Michigan 1980-1984
SERVICE Wayne State University; Course Directors Committee 2012-Present Wayne State University; SOM Promotions Committee 2009-2011 Chairman – Wayne State University; Department of Dermatology; SOM 2006-Present Co-chair – University Physician Group; Strategic Planning Committee 2006-2010 Specialist & Chief – Karmanos Cancer Institute 2006-Present
QF.6.2.1.01 2 08/02/2016
SERVICE (Community) Dermatology Foundation Board of Trustees 2009-Present Oakwood Champions of Care; WJR AM760 2009 Co-Chairman of Annual Fund Drive – United Way of Monroe County 2003-2008 Trustee – Meadow Montessori School 1997-2003
SERVICE (Scholarly Service) Reviewer – Journal of Dermatologic Surgery 2012-Present Reviewer – American Journal of Dermatopathology 2008-Present Assistant Editor – International Journal of Dermatology 2001-Present Reviewer – Journal of Cutaneous Pathology 2001-Present Editorial Board of Cutis 1998-Present
SERVICE (Other) American Acade my of Dermatology Non Melanoma Skin Cancer Workgroup 2013-2014 Dermatology Foundation Leader Society State Chair 2009 Dermatology Foundation Leader Society Michigan Vice-Chair /Chair 2000-2010 Director – American Society of Dermatopathology Quality Assurance Program 1994-1998
TEACHING Professor – Wayne State University; Detroit, MI 2006-Present 2nd year Undergraduate Dermatology Pathophysiology Course 2005-Present Weekly review of Dermatopathology lecture for Residents/Fellows Faculty Advisor for Dermatology Interest Group Mentor for 1st and 2nd year Medical Student Groups Clinical Assistant Professor, Pathology, University of Toledo; Toledo, OH 2004-Present
GRANTS, CONTRACTS, AND OTHER FUNDING
Hitachi Medical Company. Ultrasound Elastography Grant 2010
Radiologic Society of North America 2010 Diagnostic Imaging Grant for Student Research
Dermatology Foundation; Institutional Program Grant; PI; 2009-2010 $10,000 over one year period
CLINICAL TRIALS ACTIVITIES Abbott Study; Co-PI; Looking at the effects of supplemental antioxidants on the effectiveness of Humira on the treatment of psoriasis
PUBLICATIONS Peer-Reviewed Publications 1. Dermatofibrosarcoma Protuberans Masquerading as a Benign Scar on the Shoulder of a Caucasion Female. Sklar LR, Bui MR, Kado JA, Mehregan DR, Leithauser LA. J Dermatology and Clinical Research 2015 Oct 18.
2. Biopsies of nevi in children and adoescents in the United States 2009-2013. Oliveria SA, Selvam N, Mehregan D, Marchetti MA, Divan HA, Dasgeb B, Halpern AC. JAMA Dermatology 2015 Apr;151(4):447-8.
3. Identifying Toll-like receptor expression in cutaneous sarcoidosis. Huizenga T, Kado J, Mehregan DR, Diamond S. Am J Dermatology 2015 Jan;37(1):67-72
4. A survery of self-reported skin disease in the elderly African-American population. Caretti KL, Mehregan DR, Mehregan DA. Int J Dermatology 2014 Nov 27; 10.1111
QF.6.2.1.01 3 08/02/2016
5. Multiscale BerEp4 Molecular Imaging of Microtumor Phantoms: Toward Theranostics for Basal cell carcinoma. Dasgeb B, Smirnov AV, Ardeshirpour Y, Sackett DL, Knutson JR, Mehregan D, Gandjbakhche A, Halpern AC. Mol Imaging 2014 Jul 1; 13(0):1-9.
6. Eradication of Multiple Primary and Metastatic Melanoma Types in Vitro by Human Recombinant Dnase1. Rosner K, Kirou E, Mehregan D, Abrams J, Kim S, Rosner T. J Expt Derm Clin Res. 2014, 1:004.
7. Melanoma Development and Progression Are Associated with Rad6 Upregulation and β-Catenin Relocation to the Cell Membrane. Rosner K, Mehregan DR, Kirou E, Abrams J, Kim S, Campbell M, Frieder J, Lawrence K, Haynes B, Shekhar MP. J Skin Cancer. 2014; 2014:439205
8. Rad6 is a Potential Early Marker of Melanoma Development. Rosner K, Adsule S, Haynes B, Kirou E, Mehregan DR, Shekhar MP. Transl Oncol. 2014 May12. (Epub)
9. A dermatology surgical safety checklist: an objective resident performance tool. Diamond S, El Tal AK, Mehregan D. Int J Dermatol. 2013 Oct; 52(10): 1231-4.
10. Prospective histologic examinations in patients who practice traumatic hairstyling. Uhlenhake E, Mehregan D. Int J Dermatol. 2013 Dec; 52(12): 1506-12.
11. A case of idiopathic follicular mucinosis treated with bexarotene gel. Heyl J, Mehregan D, Kado J, Campbell M. Int J Dermatol. 2013 Aug 22 (Epub).
12. An introduction to primary skin imaging. Dasgeb B, Kainerstorfer J, Mehregan D, Van Vreede A, Gandjbakhche A. Int J Dermatol. 2013 Nov; 52(11): 1319-30.
13. Annular hypopigmented mycosis fungoides: a novel ringed variant. Uhlenhake EE, Mehregan DM. J Cutan Pathol. 2012 May; 39(5): 535-9.
14. Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma. Dasgeb B, Mohammadi T, Mehregan DR. Biomarkers in Cancer. 2013 Jun; 5: 7-11.
15. Shiitake dermatitis. Mehregan DR, Boutros M, Dreifke M, Rettig N. The Dermatologist. 2013 March.
16. Mapping Toll-Like Receptor Activity in Different Stages of Cutaneous T-Cell Lymphoma. Kado JA, Shango M, Mehregan C, Mehregan DR. Am J Dermatopathol. 2012 Oct; 34(7):691-8.
17. Cowden Syndrome: Report of Two Cases With Immunohistochemical Analysis for PTEN Expression. Zabetian S, Mehregan DR. Am J Dermatopathol. 2012 Aug; 34(6):632-4.
18. Basal Cell Carcinoma in Skin of Color. Ahluwalia J, Hadjicharalambous E, Mehregan DR. J of Drugs in Derm Volume 11. 2012; 4:484-486.
19. Adult Colloid Milium: A case report and literature review. Mehregan DR, Hooten, J. Int J Dermatol. 2011; 50:1531-1534.
20. Gianotti-Crosti: A case report of Gianotti-Crosti post vaccination with MMR and dTaP. Atanasovski M, Dele-Michael A, Dasgeb B, Ganger L, Mehregan DR. Int J Dermatol. 2011; 50:609-610.
21. Quantified Ultrasound Elastogrophy in Differentiating Malignant from Benign skin Neoplasm. Dasgeb B, Mehregan DR, Siegel E. (Submitted to Archives Derm)
22. Engineering a Waste Management Enzyme to Overcome Cancer Resistance to Apoptosis: Adding DNase1 to the Anticancer Toolbox. Rosner K, Kasprzak MF, Horenstein ACJ, Thurston HL, Abrams J, Kerwin LY, Mehregan DA, Mehregan DR. Cancer Gene Therapy. 2010 (1-12)
QF.6.2.1.01 4 08/02/2016 23. Desmoplastic Spitz Nevus: A histopathological review and comparison with desmoplastic melanoma. Nojavan H, Cribier B, Mehregan D. Ann. Dermatologie Venereol. 2009; 136:689-695.
24. Wilms Tumor I (WTI) Expression levels do not distinguish between melanoma and melanocytic nevus. Rosner K, Moosaui D, Mehregan DR. J Cutan Pathol. 2009 Oct; 36(10):1077-82.
25. Acquired leukoderma in a Regressing Congenital Nevomelanocytic nevus. Perl H, Jaber R, Mehregan D. Int J Dermatol. 2009 Aug; 48(8):870-2.
26. Scarring Alopecia: Clinical and Pathologic Study of Fifty-four African American Women. Borovicka J, Thomas L, Prince C, Mehregan D. Int. J. Dermatol. 2009 Jul; 48:840-45.
27. Immunolabeling Pattern of Cytokeratin 19 Expression May Distinguish Sebaceous Tumors from Basal Cell Carcinomas. Heyl J, Mehregan D. J Cutan Pathol. 2008 Jan; 35(1):40-5.
28. Feasibility and Diagnostic Agreement in Teledermatopathology Using a Virtual Slide System. Massone C, Peter Soyer H, Lozzi GP, Di Stefani A, Leinweber B, Gabler G, Asgari M, Boldrini R, Bugatti L, Canzonieri V, Ferrara G, Kodama K, Mehregan D, Rongioletti F, Janjua SA, Mashayekhi V, Vassilaki I, Zelger B, Zgavec B, Cerroni L, Kerl H. Hum Pathol. 2007; 38(4):546-54.
29. A New Papule and “Age Spots”. Fox GN, Mehregan DR. J Fam Pract. 2007; 56(4):278-82.
30. How to Maximize the Results of Your Skin Biopsy Specimen. Dooley V, Mehregan DR. Int. J. Dermatol. 2007; 46(7):727-33.
31. Traction Folliculitis. Fox G, Stausmire JM, Mehregan DR. Cutis. 2007; 79(1):26-30.
32. Giant Congenital Melanocytic Nevus with Neurofibroma-like Changes and Spina-bifida Occulta. Ansarin H, Soltani-Arabshahi R, Mehregan DR, Shayanfar N, Soltanzadeh P. Int J Dermatol. 2006; 45(11):1347-50.
33. Pleomorphic Hyalinizing Angiectatic Tumor of SoftParts: Case Report and Literature Review. Kader el. Tal A, Mehregan DR. J Cut Pathol. 2006; 33(5):361-364.
34. Bubble Hair. Mehregan DR, Sayoc L, Ramos D, Misra Higgins I. Int J Dermatol. 2006; 45(11)1319- 20.
35. The Contribution of Hermann Pinkus to Dermatology. Mehregan D. ÿes.-slov. Derm. 81, 2006, 2:102-106.
36. Extensive Lichenoid Drug Eruption Due to Glyburide: A Case Report and Review of the Literature. Fox GN, Harrell CC, Mehregan DR. Cutis 2005; 76(1):41-5.
37. Vesicobullous Disease. Fox GN, Swartz GL, Mehregan DR. J Fam Pract 2005; 54:355-356.
38. Molecular Diagnosis of Basal Cell Carcinoma and Other Basaloid Cell Neoplasms of the Skin by the Quantification of Gli1 Transcript Levels. Hatta N, Hirano T, Kimura T, Hashimoto K, Mehregan DR, Ansai S, Takehura K, Takata M. J Cut Pathol 2005; 23:131-136.
39. Juvenile Hyaline Fibromatosis: A Case Report and Review of the Literature. Thomas JE, Moossavi M, Mehregan DR, McFalda WL, Mahon MJ. Int J Dermatol 2004; 43:785-789.
40. Epidermal Basaloid Proliferation in Cutaneous Myxomas. Mehregan DR, Thomas L, Thomas JE. J Cut Pathol 2003; 00:1-5.
41. Familial Anetoderma. Thomas JE, Mehregan DR, Holland J, Mehregan DA. Int J Dermatol 2003; 42(1):75-77.
QF.6.2.1.01 5 08/02/2016 42. Wells’ Syndrome: A Clinical and Histopathologic Review of Seven Cases. Moossavi M, Mehregan DR. Int J Dermatol 2003; 42(1):62-67.
43. Large Cell Acanthoma. Mehregan DR, Hamzavi F, Brown K. Int J Dermatol 2003; 42(1):36-39.
44. Granuloma Faciale: Distribution of the Lesions and Review of the Literature. Radin DA, Mehregan DR. Cutis 2003; 72:213-219.
45. Zosteriform Angiolymphoid Hyperplasia with Eosinophilia. Dowlati B, Nabai H, Mehregan DR, Mehregan DA, Khaleel J. J Derm 2002; 29:178-179.
46. The Utility of Staining with Anti-BCG Antibodies as a Screen for Sporotrichoid Infections. Byrd J, Mehregan DR. J Am Acad Derm 2001; 44:261-264.
47. Expression of Apoptosis in Merkel Cell Carcinoma of the Skin: an Immunohistochemical, Ultrastructural, DNA Ladder and Tunnel Labeling Study. Mori Y, Hashimoto K, Tanaka K, Cui CY, Mehregan DR, Stiff MA. Am J Dermatopath 2001; 23(1):16-23.
48. Genetic Changes in Sweat Gland Carcinomas. Takata M, Hasimoto K, Mehregan DR, Lee MW, Yanamoto A, Mohri S, Ohara K, Takehora K. J Cut Pathol 2000; 27(1):30-35.
49. Staining of Melanocytic Neoplasms by Melanoma Antigen Recognized by T Cells. Mehregan DR, Hamzavi I. Am J Dermatopath 2000; 22(3):247-250.
50. Cutaneous Malakoplakia: A report of Two Cases with the Use of Anti-BCG for the Detection for Micro-organisms. Mehregan DR, Mehregan AH, Mehregan DA. J Am Acad Derm 2000; 43:351-354.
51. Selective Inflammatory Effect of Systemic Fluorouracil in Actinic Keratosis. Nabai H, Mohindra R, Mehregan DR. Cutis 1999; 64:43-44.
52. Histologic Diagnosis of Cutaneous Leishmaniasis. Mehregan DR, Mehregan AH, Mehregan DA. Clinics in Dermatology 1999; 17:297-304.
53. The Cost Effectiveness of Testing for Onychomycosis versus Empiric Treatment of Onychodystrophies with Oral Antifungal Agents. Mehregan DR, Gee Susanne L. Cutis 1999; 64:407- 410.
54. Spiny Keratoderma: A Common Under-reported Dermatosis. Horton SL, Hashimoto K, Toi Y, Miner JE, Mehregan D, Fligiel A, Savoy LB, Aronson P. J Dermatol 1998; 25(6):353-361.
55. Cheilitis Due to Treatment with Simvastatin. Mehregan DR, Mehregan DA, Pakideh S. Cutis 1998; 62:197-198.
56. Intertriginous Granular Parakeratosis. Mehregan DR, Mehregan DA, Thomas J. J Am Acad Derm 1998; 39:495-496.
57. Pathophysiology of Urticarial Vasculitis. Mehregan DR, Gibson LE. Archives of Dermatology 1998; 134:88-89.
58. Staining of Eccrine and Apocrine Neoplasms and Metastatic Adenocarcinoma with IKH-4, a Monoclonal Antibody Specific for the Eccrine Gland. Ishihara M, Mehregan DR, Hashimoto K, Yotsumoto S, Toi Y, Pietruk T, Mehregan AH, Mehregan DA. J Cut Pathol 1998; 25:100-105.
59. Histopathology of Cutaneous Leishmaniasis. Mehregan DR, Mehregan DA, Mehregan AH. Gulf J Derm 1997; 4:1-9.
60. Onychomycosis. Mehregan DA, Mehregan DR, Rinker A. Cutis 1997; 59:247-248.
QF.6.2.1.01 6 08/02/2016 61. Giant Cerebriform and Disseminated Molluscum Contagiosum in Atopic Dermatitis. Kuechle M, Mehregan DR, Roenigk RK, Muller SA. Eur J Dermatol 1996; 6:274-277.
62. Superficial Spread in Basal Cell Carcinoma. Mehregan AH, Mehregan DA, Mehregan DR. Gulf Journal of Derm 1996; 3:30-31.
63. Amelanotic Lentigo Maligna Melanoma. Rahbari HR, Nabai H, Mehregan AH, Mehregan DA, Mehregan DR, Lipinski J. Cancer 1996; 77:2052-2057.
64. Nodular Myxoid Change in Melanocytic Nevi: A Report of Two Cases. Mehregan DR, Mehregan AH, Mehregan DA. Am J Dermatopath 1996; 18(4):400-402.
65. Chronic Lupoid Leishmaniasis: Evaluation by Polymerase Chain Reaction. Momeni AZ, Yotsumoto S, Mehregan DR, Mehregan AH, Mehregan DA, Aminjavaheri M, Fujiwara H, Tada J. Arch Derm 1996; 132:198-202.
66. Immunohistochemistry: A Prognostic as Well as Diagnostic Tool? Mehregan DR, Mehregan DA. Seminars in Cutaneous Medicine and Surgery 1996; 15:317-315.
67. Sebaceous Epithelioma: A Review of Twenty-one Cases. Dinneen A, Mehregan DR. J Am Acad Derm 1996; 34:47-50.
68. Axillary Granular Parakeratosis. Mehregan DA, Vandersteen P, Sikorski L, Mehregan DR. J Am Acad Derm 1995; 33(2):373-375.
69. Proliferating Cell Nuclear Antigen in Deep-Penetrating Nevi. Mehregan DR, Mehregan DA, Mehregan AH. J Am Acad Derm 1995; 33:685-687.
70. Epidermotropic Metastatic Malignant Melanoma. Mehregan DA, Bergeon MT, Mehregan DR. Cutis 1995; 55(4):225-227.
71. Spindle Cell Lipomas: A Report of Two Cases: One With Multiple Lesions. Mehregan DR, Mehregan DA, Mehregan AH, Dorman MA, Cohen E. J Derm Surg Onc 1995; 21:796-798
72. Cutaneous Reactions to Granulocyte-Monocyte Colony-Stimulating Factor. Mehregan DR, Fransway AF, Edmonson JH, Leiferman KM. Arch Derm 1992; 128:1055-1059.
73. Cutaneous Angiomyolipoma. Mehregan DA, Mehregan DR, Mehregan AH. J Am Acad Derm 1992; 27:331-333.
74. Paraneoplastic Pemphigus: A Subset of Patients with Pemphigus and Neoplasia. Mehregan DR, Oursler JR, Leiferman KM, et al. J Cut Pathol 1993; 20:203-210.
75. Benign Lymphangioendothelioma: Report of 2 Cases. Mehregan DR, Mehregan AH, Mehregan DA. J Cut Pathol 1992; 19:502-505.
76. Coma Blister Associated with Diabetic Ketoacidosis. Mehregan DR, Daoud M, Rogers RS. J Am Acad Derm 1992; 27:269-270.
77. Cyclosporine Treatment for Dermatomyositis/Polymyositis. Mehregan DR, Su WPD. Cutis 1993; 51:59-61.
78. Pemphigus Vulgaris Appearing in Post-surgical Sites. Mehregan DR, Gibson LE, Roenigk RK. Arch Derm 1992; 128(3):414-415.
79. Urticarial Vasculitis: A Histopathologic and Clinical Review of 72 Cases. Mehregan DR, Hall MJ, Gibson LE. J Am Acad Derm 1992; 26:441-8.
QF.6.2.1.01 7 08/02/2016 80. Epithelioid Histiocytoma. Mehregan AH, Mehregan DR, Broecker A. J Am Acad Derm 1992; 26:243- 246.
81. Cutaneous Synovial Hemangioma. Mehregan DR, DuCollier D, Mehregan AH, Gibson LE. J Am Acad Derm 1991; 25:851-852.
82. Cutaneous Synovial Hemangioma. Mehregan DR, DuCollier D, Mehregan AH, Gibson LE. J Am Acad Derm 1991; 25:851-852.
83. Phenotype, Ultrastructure and Function of CD1+DR+Epidermal Cells that Express CD36 (OKM5) in Cutaneous T-cell Lymphoma. Lisby S, Baadsgaard O, Cooper KD, Hansen ER, Mehregan D, Thomsen K, Allen E, Vejlsgaard GL. Scand J Immunol 1990; 32:111-120.
84. Staining of Amyloid with Cotton Dyes. Yanagihara M, Mehregan AH, Mehregan DR. Arch Derm 1984; 120:1184-1185.
TEXTBOOK CHAPTERS 1. Wells’ Syndrome. Mehregan DR. Handbook of Skin Disease with Evidence-Based Treatment. Wolters Kluwer Pub. Netherlands. Ed. Saradana K., 2011.
2. Sweat Gland Tumors. Mehregan DR, Mehregan DA, Goncharuk V. Skin Cancer. Ed. Nouri K., 2008.
3. Follicular Tumors. Mehregan DR, Mehregan DA, Hanson E. Skin Cancer. Ed. Nouri K., 2008.
4. Granuloma Faciale. Mehregan DR, Mehregan DA. Fitzpatrick’s Dermatology in General Medicine. Ed. Katz S., 2007. pp302-304.
5. Porocarcinoma. Mehregan DR, Mehregan DA. WHO Classification of Tumors: Tumors of Skin. IARC Press. Lyon, 2006. pp128-130.
6. Pinkus' Guide to Dermatohistopathology. Sixth Ed. Mehregan AH, Hashimoto K, Mehregan DA, Mehregan DR. Appleton and Lange, 1995.
7. Paraneoplastic syndromes in dermatology. Mehregan DA, Mehregan DR. Advances in Dermatology. Callen (Ed). Volume 9, 1993.
8. Parasitic infestations of the skin. Mehregan DR, Su WPD. Conn's Current Therapy, 1993.
9. Activation of reactive versus malignant T-cells in cutaneous T-cell lymphoma: Role of abnormal antigen presenting cells and T-cell activating molecules. Cooper KD, Meunier L, Ho V, Baadsgaard O, Lee M, Hansen E, Lisby S, Mehregan D, Allen E, Vejlsgaard G, Elder J. Symposium on basic mechanisms of physiologic and lymphoproliferation in the skin, 1992.
ELECTRONIC CHAPTERS 1. Mehregan DR, Heyl J, Ha mzavi I. Dermatologic Manifestations of Urticarial Vasculitis. In: James WD, Elston DM (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.medscape.com/article/1085087-overview). St. Petersburg: eMedicine Corporation, 2014 (revision).
2. Mehregan DR, Heyl J. Premalignant Fibroepithelial Tumor (Pinkus Tumor). In: James WD, Elston DM (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.medscape.com/article/1101357-overview). St. Petersburg: eMedicine Corporation, 2014 (revision).
3. Mehregan DR, Heyl J. Pigmented Purpuric Dermatitis. In: James WD, Elston DM (eds.); eMedicine Dermatology, Online Textbook of Dermatology (www.emedicine.medscape.com/article/1084594-
QF.6.2.1.01 8 08/02/2016 overview). St. Petersburg: eMedicine Corporation, 2014 (revision).
4. Mehregan DR, Pellicane B. Large Cell Acanthoma. In: Anderson B. (ed.); CDS: Dermatology. 2012.
ABSTRACTS 1. Engineering a Waste-Management Nuclease to Overcome Melanoma’s Resistance to Apoptosis. Rosner K, Kasprzak M, Horenstein A, Thurston H, Abrams J, Kerwin L, Mehregan D. Pigment Cell & Melanoma Res. 2010; 23:709.
2. Mapping Toll-like Receptor Activity in Different Stages of Cutaneous T-cell Lymphoma. Kado JA, Mehregan DR. J Invest Derm. 2010; 130:S26.
3. Staining of Melanocytic Neoplasms with Antibodies to the Mart-1 Antigen (Melanoma Antigen Recognized by T-Cells). Mehregan DR. Am J Dermatopath 1998; 20(6):32.
4. Paraneoplastic Pemphigus. Mehregan DR, Leiferman KM, Muller SA, Anhalt G, Peters MS. J Cut Pathol 1991; 18:380.
5. Cutaneous Reactions to GMCSF. Mehregan DR, Fransway AF, Edmonson JH, Leiferman KM. J Invest Derm 1991; 96:574.
6. Urticarial Vasculitis: A Histopathologic and Clinical Review of 72 Cases. Mehregan DR, Gibson LE. J Cut Pathol 1990; 17:308.
PRESENTATIONS American Academy of Dermatology 2015 Basic Dermatopathlogy Inflammatory Course: Genodermatosis Denver, CO
American Society of Dermatopathology 2015 Dermatopathology Review Course: Immunohistochemical stains Atlanta, GA
Children Hospital of Michigan Grand Rounds 2015 Updates on Melanocytic Lesions in Children Detroit, MI
University of Detroit Mercy Physicians Assistant Program 2015 Diagnosis and Treatment of Inflammatory Skin Disease Detroit, MI
North American Clinical Dermatology Society Annual Meeting 2015 Clinical Pathologic Correlation between dermoscopy and histology Reykavic, Iceland
William Beaumont Hospital Oakland University Medical School Pediatric Grand Rounds 2015 Update on Melanocytic Lesions in Children Royal Oak, MI
Wayne State University Physician Assistant Program 2015 Diagnosis and Treatment of inflammatory skin diseases Detroit, MI
Wayne State University Department of Dermatology 2015 Dermatopathology Review Course Detroit, MI
QF.6.2.1.01 9 08/02/2016
American Society of Dermatopathology 2015 Annual Meeting: What I’ve Learned Chicago, IL
American Society of Dermatopathology 2014 Atlanta, GA Presentation: Dermatopathology Fellow Review course Immunohistochemical Stains
American Academy of Dermatology Annual Meeting 2014 Denver, CO Presentation: Dermatopathology Review course: Genodermatoses What’s New in Skin Cancer: Adnexal Neoplasms
Grand Rapids Dermatology Group 2014 Grand Rapids, MI Presentation: Journal Club Clinical Pathologic Correlation
Wayne State University Physician Assistant Course 2014 Detroit, MI Presentation: Treatment of Common Dermatologic Rashes
Dermatopathology Review Course 2014 Wayne State University Detroit, MI
Noninvasive Imaging of Skin Tumors 2014 European Academy of Dermatology and Venereology Amsterda m, Netherlands
American Academy of Dermatology 2013 Miami, FL Presntation: Tumor Board; Adnexal Neoplasms
Grand Rapids Dermatology Group 2013 Grand Rapids, MI Presentation: Journal Club Melanoma Treatment Update
American Society of Dermatopathology 2013 Washington D.C. Presentation: Dermatopathology Fellow Board Review
Maryland Dermatologic Society 2013 Presentation: Histologic Correlates of Dermoscopy Findings
International Society of Dermatology – Regional Colloquium 2012 Durban, South Africa Presentation: Dermatopathology Forum
American Society of Dermatopathology 2012 Chicago, IL Presentation: Dermatopathology Fellow Board Review
Great Lakes Family Practice Meeting 2011 Birmi ngha m, MI Presentation: Update in Dermatologic Therapy
QF.6.2.1.01 10 08/02/2016 International Society of Dermatology 2011 St. Petersburg, Russia Presentation: Optimizing the results of your skin biopsies
American Society of Dermatopathology 2011 Seattle, WA Presentation: Dermatopathology Fellow Board Review
Iranian Dermatology Society 2011 Tehran, Iran Presentation: Dermatopathology Workshop
NIH Department of Pathology 2011 Bethesda, MD Presentation: Review of Adnexal Tumors
NIH Biophotonics Laboratory 2011 Bethesda, MD Presentation: Imaging in Dermatology
Great Lakes Family Practice Meeting 2010 Birmi ngha m, MI Presentation: Update on Dermatologic Therapy
The Pigmentation and Melanoma Research Congress 2010 Vancouver, BC, Canada Presentation: Engineering a Waste Management Nuclease to Overcome Resistance of Metastatic Melanoma to Treatment
Society of Investigative Dermatology 2010 Atlanta, GA Presentation: Mapping Toll-like Receptor Activity in Different Stages of Cutaneous T-cell Lymphoma
American Society of Dermatopathology 2010 Atlanta, GA Presentation: Toll-like Receptor Activity in Cutaneous T-cell Lymphoma
Vars Dermatopathology Retreat 2010 Vars, France Presentation: Ultrasound Imaging of Cutaneous Neoplasms
American Academy of Dermatology Annual Meeting 2009 San Francisco, CA Presentation: Introduction to Dermatopathology
Egyptian Society of Dermatology Annual Meeting 2009 Al-Minya University Presentation: Adnexal Tumor Workshop Presentation: Genetic Syndromes with Increased Risk of Cancer Presentation: Difficult Melanocytic lesions
American Society of Dermatopathology Annual Meeting 2009 Chicago, IL Presentation: Evening Slide Symposium
Great Lakes Family Medicine Update 2009 Troy, MI
QF.6.2.1.01 11 08/02/2016 Presentation: Common Skin Diseases in Primary Care
Washington Dermatology Society Annual Meeting 2008 Georgetown University - Washington, D.C. Presentation: How to Maximize the Results of Your Skin Biopsy Specimen
International Society of Dermatopathology Annual Meeting 2008 San Antonio, TX Presentation: Self Assessment in Dermatopathology
Texas Dermatologic Society Bi-Annual Meeting 2008 San Antonio, TX Presentation: Alopecia and How to Maximize the Results of Your Skin Biopsy Specimen
Grand Rounds 2008 Karmanos Cancer Institute Presentation: Dermatologic Syndromes with Increased Cancer Risk
International Society of Dermatopathology Annual Scientific Meeting 2007 Washington, D.C. Presentation: Contributions of Hermann Pinkus to Dermatology
Egyptian Society of Dermatology 2007 Al-Minya University Presentation: Update on Immunostains Presentation: Overview of Inflammatory skin diseases
O’Leary Meeting – Minnesota Dermatology Society 2007 Mayo Clinic – Rochester, Minnesota Presentation: Dermatopathology Self Assessment
Grand Rounds 2006 Roosevelt St. Luke’s Dermatology Department Presentation: Alopecia
Michigan State Medical Society 2005 Annual Scientific Meeting Presentation: Maximizing the results of your skin biopsy
International Society of Dermatology 2005 Prague Dermatology Symposium Presentation: Contributions of Hermann Pinkus to Dermatology
International Society of Dermatology 2004 Regional Colloquium, Tehran, Iran Presentation: Dermatopathology Self-Assessment Presentation: Challenging Melanocytic Lesions Presentation: Adnexal Tumor Course
American Society of Dermatopathology 2004 Annual Meeting, Boston, Massachusetts Poster: Desmoplastic Spitz Nevus
Michigan State Medical Society 2003 Annual Scientific Meeting Presentation: Update on Melanocytic Lesions
International Society of Dermatopathology 2000
QF.6.2.1.01 12 08/02/2016 San Francisco, CA Presentation: Self-Assessment Examination
Iranian Society of Dermatology 2000 Tehran, Iran Presentation: Histopathology of Alopecias Dermatopathology Review Michigan Dermatology Society 1999 Sacred Heart Seminar Presentation: Histologic Diagnosis of Alopecias
American Society of Dermatopathology 1998 Presentation: Staining of Melanocytic Neoplasms by MART-1 (Melanoma Antigen Recognized by T-Cells)
International Society of Dermatopathology 1998 Madrid, Spain Presentation: Staining of Benign & Malignant Melanocytic Neoplasms by MART-1
American Academy of Dermatology 1998 Poster: Staining of Benign and Malignant Neoplasms with antibodies to Mart-1
American Society of Dermatopathology 1995 Poster: Lupoid Leishmaniasis
GCCC League of Dermatology 1995 Third International Conference, Bahrain Presentation: Chronic Lupoid Leishmaniasis; Diagnostic Markers in Dermatopathology
Third Regional Dermatopathology Colloquium 1995 Cairo, Egypt Presentation: Chronic Lupoid Leishmaniasis; Immunohistochemical Stains in Dermatopathology
International Society of Dermatopathology 1994 Poster: PCNA Staining in Deep Penetrating Nevi
American Academy of Dermatology 1993 Presentation: Urticarial Vasculitis
World Congress of Dermatology 1992 Poster: Urticarial Vasculitis Presentation: Coma Bullae Associated with Diabetic Ketoacidosis
Society of Investigative Dermatology 1991 Poster: Cutaneous Reactions to GMCSF
American Society of Dermatopathology 1991 Plenary Presentation: Paraneoplastic Pemphigus
Minnesota Dermatologic Society 1990 Case Presentation: Cyclosporine and Dermatomyositis Case Presentation: Giant Cerebriform Molluscum Contagiosum
American Society of Dermatopathology 1990 Poster: Urticarial Vasculitis
QF.6.2.1.01 13 08/02/2016
QF.6.2.1.01 14 08/02/2016